Telehealth unlikely to be cost effective for patients with long term conditions

March 21, 2013

Telehealth does not seem to be a cost effective addition to standard support and treatment for patients with long term conditions, finds a study published in the BMJ today.

The findings follow a BMJ study published last month showing that telehealth does not improve quality of life for patients with long term conditions.

Telehealth uses technology to help people with live more independently at home. For example, blood pressure or can be measured at home and electronically transmitted to a health professional, reducing the need for hospital visits.

Telehealth has been promoted to reduce while improving health related quality of life, but there is very little good quality evidence on the effect of telehealth on service use and costs.

So, a team of UK researchers examined the costs and of telehealth compared with usual care over 12 months in 965 patients with a long term condition (, or diabetes).

The study is part of the Whole Systems Demonstrator Trial - one of the largest and most comprehensive investigations of telehealth and telecare ever conducted.

Of the 965 patients, 534 received telehealth equipment and support, while 431 received usual care. The results took account of costs to both health and social care systems.

The cost per quality adjusted life year (QALY) - a combined measure of quantity and quality of life – of telehealth when added to usual care was £92,000. This is well above the cost effectiveness threshold of £30,000 set by the UK National Institute for Health and (NICE). The probability of cost effectiveness was low (11%).

Even when the effects of equipment price reductions and increased working capacity of services were combined, the probability that telehealth is cost effective was only about 61%, at a threshold of £30 000 per QALY.

The authors say that the QALY gain by people using telehealth in addition to standard support and treatment was similar to those receiving usual care, and total costs for the telehealth group were higher. As such they conclude that "telehealth does not seem to be a cost effective addition to standard support and treatment."

More information: Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial, BMJ, 2013.

Related Stories

Recommended for you

Can four fish oil pills a day keep the doctor away?

July 7, 2015

Fish oil is one of the most popular dietary supplements in the U.S. because of the perceived cardiovascular benefits of the omega-3 it contains. However, scientific findings on its effectiveness have been conflicting. New ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.